https://www.selleckchem.com/pr....oducts/levofloxacin-
41; 95 %CI [4.05-32.14]; p 0.01) and 24 % (16/67) of asymmetries (OR = 27.01; 95 %CI [9.41-77.48]; p 0.01). No significant difference was noted in the malignant versus benign biopsy outcomes among the recalled DBT lesion types (p = 0.71). Recalled masses from screening DBT were more likely to be worked up with ultrasound alone compared to all other non-calcified lesion types and more likely to represent true lesions on diagnostic evaluation. Recalled asymmetries and focal asymmetries were more likely to be w
Like
Comment
Share
